Group 1 - The acrylic acid concept increased by 2.64%, ranking third among concept sectors, with 13 stocks rising, including Hongqiang Co., which hit the daily limit, and Bohai Chemical, Taihe Technology, and Satellite Chemical, which rose by 7.56%, 6.71%, and 6.67% respectively [1] - The acrylic acid sector saw a net inflow of 329 million yuan from main funds, with 10 stocks receiving net inflows, and 5 stocks exceeding 10 million yuan in net inflow, led by Wanhua Chemical with a net inflow of 174 million yuan [2] - The top stocks by net inflow ratio included Hongqiang Co., ST Shenhua, and Daoshengtian, with net inflow ratios of 42.22%, 11.79%, and 5.01% respectively [3] Group 2 - The top performers in the acrylic acid sector included Wanhua Chemical with a 4.39% increase, Tianlong Group with a 6.04% increase, and Hongqiang Co. with a 10.00% increase [3] - The stocks with the largest declines included Guoen Co. with a decrease of 2.04%, Brother Technology with a decrease of 0.87%, and Akoli with a decrease of 0.61% [4] - The trading volume and turnover rates varied, with Hongqiang Co. having a turnover rate of 10.78% and Tianlong Group at 26.90% [3][4]

阿科力（603722）(603722.SH)发布2025年度业绩预告，预计2025年度实现归属于母公司所有者净亏损 3150万元至3850万元。2025年度，公司主要产品聚醚胺受国内新增产能释放影响，产品价格一直处于低 位，公司新产品仍处于客户测试及推广阶段，虽有订单但暂未对公司业绩产生重大影响。 ...

智通财经APP讯，阿科力(603722.SH)发布2025年度业绩预告，预计2025年度实现归属于母公司所有者 净亏损3150万元至3850万元。2025年度，公司主要产品聚醚胺受国内新增产能释放影响，产品价格一直 处于低位，公司新产品仍处于客户测试及推广阶段，虽有订单但暂未对公司业绩产生重大影响。 ...

证券代码：603722 证券简称：阿科力 公告编号：2026-002 无锡阿科力科技股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 重要内容提示： 业绩预告的具体适用情形：净利润为负值。 经财务部门初步测算，预计 2025 年度实现归属于母公司所有者的净利润 为-3,850.00 万元到-3,150.00 万元。 预计 2025 年度实现归属于母公司所有者的扣除非经常性损益后的净利 润为-4,700.00 万元到-3,900.00 万元。 一、本期业绩预告情况 （一）业绩预告期间 预计 2025 年度实现归属于母公司所有者的扣除非经常性损益后的净利润为 -4,700.00 万元到-3,900.00 万元。 （三）本期业绩预告的财务数据未经注册会计师审计。 二、上年同期经营业绩和财务状况 （一）归属于母公司所有者的净利润：-1,965.11 万元。归属于母公司所有者 的扣除非经常性损益的净利润：-2,217.43 万元。 （二）每股收益：-0.22 元。 三、本期业绩 ...

格隆汇1月19日丨阿科力(603722.SH)公布，经财务部门初步测算，预计2025年度实现归属于母公司所有 者的净利润为-3,850.00万元到-3,150.00万元。预计2025年度实现归属于母公司所有者的扣除非经常性损 益后的净利润为-4,700.00万元到-3,900.00万元。 本期业绩预亏的主要原因：1、2025年度，公司主要产品聚醚胺受国内新增产能释放影响，产品价格一 直处于低位，公司新产品仍处于客户测试及推广阶段，虽有订单但暂未对公司业绩产生重大影响；2、 公司2025年6月推出的限制性股票激励计划需按会计准则确认股份支付费用，分摊至2025-2027年考核 期，对利润产生影响。 ...

Core Viewpoint - AkzoNobel (603722.SH) is expected to report a net loss attributable to shareholders of the parent company ranging from -38.50 million to -31.50 million yuan for the fiscal year 2025 [1] Financial Performance - The projected net profit attributable to shareholders, excluding non-recurring gains and losses, is estimated to be between -47.00 million and -39.00 million yuan for 2025 [1] Reasons for Performance Decline - The primary reason for the anticipated loss is the impact of newly released domestic production capacity on the price of the main product, polyether amine, which has remained low [1] - The company's new products are still in the customer testing and promotion phase, resulting in orders that have not yet significantly impacted the company's performance [1] - The restricted stock incentive plan set to launch in June 2025 will require the company to recognize share-based payment expenses according to accounting standards, affecting profits over the assessment period from 2025 to 2027 [1]

阿科力公告称，经初步测算，2025年度归属于母公司所有者的净利润预计为-3850.00万元到-3150.00万 元，上年同期为-1965.11万元；扣非净利润预计为-4700.00万元到-3900.00万元，上年同期为-2217.43万 元。业绩预亏主因是主要产品聚醚胺价格低位运行，新产品未产生重大影响，且限制性股票激励计划需 确认股份支付费用。具体财务数据以2025年年度报告为准。 ...

Market Overview - The Shanghai Composite Index closed at 4089.45 points, above the annual line, with a slight increase of 0.09% [1] - The total trading volume of A-shares reached 17815.48 billion yuan [1] Stocks Breaking Annual Line - A total of 124 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Keta Power (300153) with a deviation rate of 11.05% and a daily increase of 12.50% [1] - Tianjian Technology (002977) with a deviation rate of 9.75% and a daily increase of 10.00% [1] - Hongbo Pharmaceutical (301230) with a deviation rate of 9.27% and a daily increase of 10.27% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Hongdu Aviation (600316) with a daily increase of 8.58% and a deviation rate of 8.08% [1] - Jiuliang Co. (300808) with a daily increase of 5.79% and a deviation rate of 5.21% [1] - Zhongcheng Technology (920207) with a daily increase of 22.67% and a deviation rate of 4.84% [1] Summary of Stocks with Smaller Deviation Rates - Stocks that have just crossed the annual line with smaller deviation rates include: - Dongfang Guoxin (东方国信) and Fuchun Environmental (富春环保) with minimal deviation rates [1] - The table lists various stocks along with their daily performance metrics, including turnover rates and latest prices [1]

Group 1 - The core viewpoint of the news is that Akoli's stock has shown a slight increase in price and trading activity, indicating potential investor interest despite recent financial challenges [1][2] - As of January 7, Akoli's stock price rose by 2.03% to 40.20 CNY per share, with a total market capitalization of 3.928 billion CNY [1] - The company has experienced a net inflow of main funds amounting to 252.72 thousand CNY, with significant buying activity from large orders [1] Group 2 - For the period from January to September 2025, Akoli reported a revenue of 337 million CNY, reflecting a year-on-year decrease of 7.46% [2] - The net profit attributable to shareholders for the same period was -16.39 million CNY, a significant decline of 141.59% compared to the previous year [2] - The number of shareholders increased to 8,766, up by 46.74%, while the average circulating shares per person decreased by 31.85% [2] Group 3 - Since its A-share listing, Akoli has distributed a total of 198 million CNY in dividends, with 53.54 million CNY paid out in the last three years [3]

证券代码：603722 证券简称：阿科力 公告编号：2026-001 无锡阿科力科技股份有限公司 关于使用闲置自有资金委托理财的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 重要内容提示： ●委托理财受托方：中国光大银行无锡分行、中国民生银行南京分行 ●委托理财金额：人民币 5,000.00 万元、人民币 3,600.00 万元 ●委托理财产品名称：2025 年挂钩汇率对公结构性存款定制第十二期产品 577、聚赢黄金-挂钩黄金 AU9999 看涨二元结构性存款（SDGA253875V） ●委托理财期限：90 天、91 天 ●履行的审议程序：无锡阿科力科技股份有限公司第五届董事会第六次会议、 2025 年第三次临时股东会审议通过了《关于使用闲置自有资金进行委托理财的 议案》，公司对最高额度不超过 20,000 万元的闲置自有资金进行委托理财，在 确保不影响公司日常运营的情况下在股东会审议通过之日起 12 个月内滚动使用， 并授权公司总经理在上述额度内组织实施。具体内容详见公司于 2025 年 ...